Cargando…
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
The underlying neurobiological basis of major depressive disorder remains elusive due to the severity, complexity, and heterogeneity of the disorder. While the traditional monoaminergic hypothesis has largely fallen short in its ability to provide a complete picture of major depressive disorder, eme...
Autores principales: | Kadriu, Bashkim, Musazzi, Laura, Henter, Ioline D, Graves, Morgan, Popoli, Maurizio, Zarate, Carlos A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368372/ https://www.ncbi.nlm.nih.gov/pubmed/30445512 http://dx.doi.org/10.1093/ijnp/pyy094 |
Ejemplares similares
-
The Kynurenine Pathway and Bipolar Disorder: Intersection of the Monoaminergic and Glutamatergic Systems and Immune Response
por: Kadriu, Bashkim, et al.
Publicado: (2019) -
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants
por: Alitalo, Okko, et al.
Publicado: (2021) -
“Glutamatergic-based Rapid Acting Antidepressants: The Link to Synaptic Plasticity”
por: Moskal, Joseph R.
Publicado: (2017) -
Effects of Psychotherapy on Glutamatergic Neurotransmission
por: Wade-Bohleber, Laura, et al.
Publicado: (2023) -
Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023)